spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  King Pharmaceuticals 

 HSMN NewsFeed - 28 Jan 2019
Histogen Appoints Richard Pascoe as Chairman and Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Devices Oncology Dermatology Personnel
 HSMN NewsFeed - 19 Jan 2018
UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2015
Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2014
Cohera Medical, Inc.(R) Appoints Richard W. Pascoe to its Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 13 Jan 2014
KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Jul 2013
Lantheus Medical Imaging Announces Chief Financial Officer Transition
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 1 Aug 2011
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2011
Rosetta Genomics Names Brian Markison Board Chairman
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 1 Mar 2011
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jan 2011
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2010
Brian Markison to Join Rosetta Genomics Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 15 Dec 2010
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2010
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2010
Pfizer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2010
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Steve Andrzejewski Joins Nycomed US Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Jun 2010
King Pharmaceuticals Amends Strategic Alliance for REMOXY(R) in Europe
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2010
King Pharmaceuticals Announces US Department of Justice Settlement
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2009
Dean Mitchell Appointed to Talecris Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2009
FDA Issues Complete Response Letter for CorVue(TM)
Biopharmaceuticals Cardiology Radiology FDA
 HSMN NewsFeed - 17 Aug 2009
Symphogen Appoints Adriann Sax Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2009
Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jul 2009
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2009
King Pharmaceuticals Appoints John J. Howarth Vice President Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2009
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2009
New Drug Application Submitted For Acurox(r) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 24 Nov 2008
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2008
King Commences Cash Tender Offer for Alpharma at $37 Per Share
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2008
King Proposes Acquisition of Alpharma for $33 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Aug 2008
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2008
Somaxon Pharmaceuticals Appoints Richard W. Pascoe as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2008
King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Apr 2008
Neuromed Names Sean Cunliffe Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM)
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
King Pharmaceuticals Presents Positive Results of CorVue(TM) Phase III Clinical Trials at the American College of Cardiology (ACC) Annual Scientific Conference
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 24 Mar 2008
Acura Pharmaceuticals, Inc. Names Robert B. Jones Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2008
ARIAD Appoints Richard W. Pascoe as Chief Operating Officer and Expands Role of Timothy P. Clackson, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Dec 2007
Remoxy Meets Primary Endpoint in Pivotal Phase III Study
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2007
Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Oct 2007
Adenoscan(R) Patent Lawsuits Settled
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Oct 2007
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2007
Actavis Confirms its Patent Challenge of King's Avinza(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2007
King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2007
King Pharmaceuticals Announces That It is Now Distributing Bicillin(R) C-R Manufactured at Its Michigan Facility
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2007
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2007
Patient Recruitment Completed for Pivotal Phase III Study of Remoxy
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing
 HSMN NewsFeed - 21 Jun 2007
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2007
ProEthic Names James R. Lattanzi Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2007
IMPAX Announces FDA Approval of Generic Corzide
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 28 Feb 2007
King Pharmaceuticals Announces FDA Approval of ALTACE(R) Tablet Formulation
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2007
Ligand Pharmaceuticals Completes Sale of AVINZA to King Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2007
King Pharmaceuticals Completes Strategic Acquisition of AVINZA(R)
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2007
King Pharmaceuticals Announces FDA Approval of New Bicillin(R) Manufacturing Facility
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2007
King Pharmaceuticals Appoints Eric G. Carter as Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2007
Ligand Appoints John L. Higgins Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2007
King Pharmaceuticals Acquires License From Vascular Solutions to Hemostatic Products Containing King's THROMBIN-JMI(R)
Biopharmaceuticals Devices Licensing
 HSMN NewsFeed - 20 Dec 2006
Palatin Technologies and King Pharmaceuticals Complete Enrollment in Pre-Menopausal Cohort of a Phase 2 Clinical Trial Evaluating Bremelanotide in Pre- and Post-Menopausal Female Sexual Dysfunction Patients
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
King Pharmaceuticals Reports FDA Approval of New Skelaxin(R) Label
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2006
King Pharmaceuticals Board Names Brian Markison to Succeed Ted Wood as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2006
Heartscape Enrolls First Patient in OCCULT-MI Clinical Trial Using its PRIME ECG(R) System
Devices Cardiology
 HSMN NewsFeed - 9 Nov 2006
GTCR Announces Graceway Pharmaceuticals' Agreement to Acquire 3M's Pharmaceutical Business in North and Latin America
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2006
Palatin Technologies and King Pharmaceuticals Report Results For Two Phase 2B Clinical Trials Evaluating Bremelanotide in Male Erectile Dysfunction Patients
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2006
King Pharmaceuticals Reports DREAM Data on Ramipril
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Sep 2006
Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression From Pre-Diabetes To Type 2 Diabetes by 62 Percent in Largest Completed Diabetes Prevention Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Jul 2006
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Jul 2006
King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 26 Jun 2006
Vasogen Announces Initial Results from Phase III ACCLAIM Trial in Chronic Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 90

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 90 additional stories matching:
King Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.